Wei, J., Nduom, E. K., Kong, L., Hashimoto, Y., Xu, S., Gabrusiewicz, K., . . . Heimberger, A. B. (2016). MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints. Neuro Oncol.
استشهاد بنمط شيكاغوWei, Jun, et al. "MiR-138 Exerts Anti-glioma Efficacy By Targeting Immune Checkpoints." Neuro Oncol 2016.
MLA استشهادWei, Jun, et al. "MiR-138 Exerts Anti-glioma Efficacy By Targeting Immune Checkpoints." Neuro Oncol 2016.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.